Trial Condition(s):

Diabetes Mellitus

Special Drug Use Investigation of Glucobay OD

Bayer Identifier:

16517

ClinicalTrials.gov Identifier:

NCT01685502

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The objective of this study is to assess the efficacy and safety under practical use of Glucobay OD. A total of 5,000 patients are to be enrolled to the study and assessed during 1 year observation period.

Inclusion Criteria
- Glucobay OD naive diabetics. patients with at least one of the following conditions: Uncontrollable with dietary therapy,exercise cure, diabetes medication, insulin therapy.
Exclusion Criteria
- Patients who are contraindicated based on the product label

Trial Summary

Enrollment Goal
2289
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Glucobay ODT (Acarbose, BAYG5421)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Japan

Status
Completed
 

Trial Design